HRMY

Harmony Biosciences Holdings, Inc. [HRMY] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

HRMY Stock Summary

Top HRMY Correlated Resources

HRMY

Top 10 Correlated ETFs

HRMY

Top 10 Correlated Stocks

HRMY

In the News

HRMY Financial details

Company Rating
-
Market Cap
1.67B
Income
128.85M
Revenue
582.02M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
246
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
12.94
Forward P/E
-
PEG
-4.37
P/S
3.52
P/B
4.05
P/C
-
P/FCF
9.12
Quick Ratio
3.9
Current Ratio
4.12
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.16
EPS next Y
-
EPS next Q
-
EPS this Y
-29.32%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
149.71%
Revenue Q/Q
5.08%
EPS Q/Q
-28.13%
-
-
-
-
SMA20
-12.12%
SMA50
-23.68%
SMA100
-17.14%
Inst Own
-
Inst Trans
-
ROA
19%
ROE
33%
ROC
0.3%
Gross Margin
81%
Oper. Margin
37%
Profit Margin
28%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
18.611-39.265
52W High
-24.38%
52W Low
+63.83%
RSI
45
Rel Volume
0.73
Avg Volume
357K
Volume
261.84K
Perf Week
1.06%
Perf Month
-14.27%
Perf Quarter
-11.73%
Perf Half Y
-17.51%
-
-
-
-
Beta
0.725
-
-
Volatility
0.21%, 2.22%
Prev Close
0.17%
Price
29.49
Change
0.17%

Something similar

Top by Market Cap
LLY
ABEC.DE
META
JPM
1YD.DE
Top Correlated ETFs
PILL
FTXH
HHL.TO
HHLE.TO
CURE
Top Correlated Stocks
UPS
AACAY
PFE
LYB
SWK
Similar Market Cap
911622.TW
IXN
NRIIX
1051.HK
1769.HK

Company Profile

Healthcare Biotechnology
  • Volume Average 357K
  • Market Capitalization 1.67B
  • Employee 246
  • CEO Dr. Jeffrey M. Dayno M.D.
  • Headquarters Plymouth Meeting,PA,US
  • IPO Date 2020-08-19
  • Website https://www.harmonybiosciences.com

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.